Amgen News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

26.11.24	Amgen Says Its Weight Loss Drug Candidate MariTide Reduced Weight Up To 20 Percent In Phase 2 Study (RTTNews)
13.11.24	Amgen Says No Link Between MariTide And Changes In Bone Mineral Density (RTTNews)
30.10.24	Amgen Inc. Q3 Profit Increases, Beats Estimates (RTTNews)
15.10.24	Amgen Reports Positive Phase 3 Data For Uplizna In Generalized Myasthenia Gravis (RTTNews)
30.09.24	Biotech Stocks Facing FDA Decision In October 2024 (RTTNews)
25.09.24	Amgen's TEPEZZA Approved In Japan For Treatment Of Active Thyroid Eye Disease (RTTNews)
06.08.24	Amgen Inc. Q2 Profit Decreases, But Beats Estimates (RTTNews)
05.06.24	Amgen Reports Positive Results For Phase 3 Trial Of Uplizna For IgG4-RD (RTTNews)
30.05.24	Biotech Stocks Facing FDA Decision In June 2024 (RTTNews)
30.05.24	Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris (RTTNews)
22.05.24	Roche: FDA Grants Breakthrough Device Designation For Bood Test Measuring Lp(a) (RTTNews)
20.05.24	AstraZeneca: New Data Shows Tezspire's Role In Future COPD Treatment (RTTNews)
17.05.24	Amgen: FDA Approves Imdelltra For Extensive-Stage Small Cell Lung Cancer Treatment (RTTNews)
02.05.24	Amgen Inc. Q1 Earnings Summary (RTTNews)
26.04.24	Amgen Announces Imminent Submission Of MAA To European Medicines Agency For Teprotumumab (RTTNews)
26.02.24	Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs (RTTNews)
06.02.24	Amgen Inc. Q4 Profit Decreases, but beats estimates (RTTNews)
19.01.24	Verastem : Avutometinib Combination Receives Fast Track Designation For KRAS G12C-Mutant NSCLC (RTTNews)
26.12.23	Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS (RTTNews)
26.12.23	AMGEN PROVIDES REGULATORY UPDATE ON STATUS OF LUMAKRAS® (SOTORASIB) (PR Newswire)
14.12.23	Amgen Appoints David Reese As Chief Technology Officer (RTTNews)
14.12.23	AMGEN ANNOUNCES EXECUTIVE APPOINTMENTS TO ACCELERATE INNOVATION (PR Newswire)
14.12.23	AMGEN TO SPONSOR THE IRISH OPEN (PR Newswire)
13.12.23	FDA Grants Priority Review To Amgen's Application For Small Cell Lung Cancer Treatment (RTTNews)
13.12.23	FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer (PR Newswire)
12.12.23	AMGEN ANNOUNCES 2024 FIRST QUARTER DIVIDEND INCREASE TO $2.25 PER SHARE (PR Newswire)
08.12.23	AMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023 (PR Newswire)
30.11.23	Biotech Stocks Facing FDA Decision In December 2023 (RTTNews)
22.11.23	AMGEN TO PRESENT AT THE EVERCORE ISI HEALTHCONX CONFERENCE (PR Newswire)
10.11.23	AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023 (PR Newswire)
07.11.23	AMGEN PRESENTS NEW RESEARCH IN EARLY PSORIATIC ARTHRITIS AT ACR 2023 (PR Newswire)
07.11.23	AMGEN PRESENTS NEW DATA FROM PHASE 2 TRIAL OF DAZODALIBEP IN SJÖGREN'S SYNDROME AT ACR 2023 (PR Newswire)
06.11.23	Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition (PR Newswire)
02.11.23	AMGEN PRESENTS NEW DATA THAT SHOW BLOOD PRESSURE DECREASES FOR ADULTS TREATED WITH KRYSTEXXA® (PEGLOTICASE) (PR Newswire)
01.11.23	AMGEN TO PRESENT DATA AT ACR 2023 ACROSS EXPANDED RHEUMATOLOGY PIPELINE AND PORTFOLIO (PR Newswire)
01.11.23	FDA Approves Amgen's Wezlana For Multiple Inflammatory Diseases (RTTNews)
31.10.23	Amgen Lifts FY23 Adj. Earnings, Revenue Outlook - Update (RTTNews)
31.10.23	Amgen Inc. Q3 Profit Decreases, but beats estimates (RTTNews)
25.10.23	AMGEN ANNOUNCES WEBCAST OF 2023 THIRD QUARTER FINANCIAL RESULTS (PR Newswire)
24.10.23	AMGEN ANNOUNCES 2023 FOURTH QUARTER DIVIDEND (PR Newswire)
22.10.23	AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX® (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER (PR Newswire)
20.10.23	AMGEN PRESENTS NEW TARLATAMAB DATA IN SMALL CELL LUNG CANCER (PR Newswire)
19.10.23	AMGEN TO WEBCAST INVESTOR CALL AT ESMO 2023 (PR Newswire)
16.10.23	AMGEN TO PRESENT NEW RESEARCH FROM ONCOLOGY PORTFOLIO AND PIPELINE AT ESMO 2023 (PR Newswire)
06.10.23	Amgen Concludes Horizon Therapeutics Acquisition (RTTNews)
06.10.23	AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC (PR Newswire)
04.10.23	Large-scale proteomics in population-based studies from UK and Iceland (PR Newswire)
20.09.23	AMGEN LAUNCHES PARTNERS OF CHOICE NETWORK OF EIGHT LEADING ONCOLOGY ACADEMIC CENTERS (PR Newswire)
11.09.23	AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
10.09.23	Amgen Reports Positive Data From Phase 1 Study Of Lumakras Combination In Non-small Cell Lung Cancer (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

17:58		Handel in Frankfurt: SDAX liegt letztendlich im Plus
17:58		Schwache Performance in Europa: Euro STOXX 50 gibt letztendlich nach
15:58		Schwache Performance in Frankfurt: TecDAX zeigt sich nachmittags schwächer
15:58		Handel in Europa: So bewegt sich der Euro STOXX 50 aktuell
15:58		XETRA-Handel: SDAX am Nachmittag freundlich
13:28		Bayer-Analyse: DZ BANK verleiht Bayer-Aktie Kaufen in jüngster Analyse
12:26		Schwacher Wochentag in Europa: So performt der Euro STOXX 50 mittags
12:26		Mittwochshandel in Frankfurt: TecDAX gibt am Mittag nach

17:58

Handel in Frankfurt: SDAX liegt letztendlich im Plus

17:58

Schwache Performance in Europa: Euro STOXX 50 gibt letztendlich nach

15:58

Schwache Performance in Frankfurt: TecDAX zeigt sich nachmittags schwächer

15:58

Handel in Europa: So bewegt sich der Euro STOXX 50 aktuell

15:58

XETRA-Handel: SDAX am Nachmittag freundlich

13:28

Bayer-Analyse: DZ BANK verleiht Bayer-Aktie Kaufen in jüngster Analyse